Cornercap Investment Counsel Inc Nektar Therapeutics Transaction History

Cornercap Investment Counsel Inc

  • $302 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023
BUY
$0.64 - $3.15 $1,424 - $7,011
2,226 Added 3.46%
66,627 $46,000
Q3 2022

Nov 14, 2022
BUY
$3.04 - $5.14 $62,067 - $104,943
20,417 Added 46.42%
64,401 $206,000
Q2 2022

Aug 15, 2022
BUY
$3.17 - $6.17 $139,429 - $271,381
43,984 New
43,984 $167,000

Others Institutions Holding NKTR

# of Institutions
152
Shares Held
130M
Call Options Held
92.7K
Put Options Held
4.9K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $157M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email